O-GlcNAcylation is required for mutant KRAS-induced lung tumorigenesis
Kekoa Taparra(Los Angeles County Department of Public Health), Phuoc T. Tran(University of Chicago Medical Center)
Cited by 81
Related Papers
Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer
|Cell|2017|521
Concurrent versus Sequential Sorafenib Therapy in Combination with Radiation for Hepatocellular Carcinoma
|PLoS ONE|2013|42
Tissue- and Blood-derived Genomic Biomarkers for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review
|European Urology Oncology|2021|39